Skip to content

Relationships and Differences Analysis in Heart Failure

Retrospektive Datenanalyse Von Herzinsuffizienzpatienten in Der Kardiologie Des Universitätsklinikums Würzburg

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03966729
Acronym
REDEAL-HF
Enrollment
3000
Registered
2019-05-29
Start date
2009-01-01
Completion date
2023-12-31
Last updated
2022-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Disease, Chronic Heart Failure, Heart Failure

Keywords

HFmrEF, HFrEF, HFpEF, Heart Failure

Brief summary

This study characterizes heart failure patients who attended the University Hospital Würzburg. The primary aim is a better understanding of the relationships and differences between the subgroups HFrEF (EF \< 40%), HFmrEF (EF 40-49%), and HFpEF (EF\>50%), contributing to an improved diagnosis, prognosis and therapy of patients with heart failure.

Detailed description

The varying clinical picture of heart failure (HF) represents a major challenge for patient care in Germany. HF is one of the most common reasons for hospitalization in the Western world. In the chronic course of heart failure, affected patients are committed to morbidity, lifelong therapy and high risk of cardiac decompensation, also associated with high mortality. Heart failure patients, who visited the Cardiology Department of the University Hospital Wuerzburg, shall be analyzed with regard to all clinical data and outcome. This retrospective work should help to better understand the three groups HFrEF (EF \< 40%), HFmrEF (EF 40-49%) and HFpEF (EF\>50%) and help identifying similarities and differences between the groups. Hereby we hope for progress in diagnostic, prognostic and therapeutic aspects of heart failure.

Interventions

OTHERTime (outcome)

Sponsors

Wuerzburg University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis: Heart failure * Minimum of two echocardiographic examinations in a minimum time frame of six months * Patients must have reached the age of 18

Design outcomes

Primary

MeasureTime frameDescription
Long-term survival in heart failure patients with preserved, mid-range or reduced left ventricular ejection fraction1 year follow up after last examinationSurvival of patients with heart failure extracted from medical record or by telephone interview

Secondary

MeasureTime frameDescription
Impact of clinical imaging and laboratory parameters on long-term survival in heart failure patients with precerved, mid-range or reduced left ventricular ejection fraction6 monthsParameters are derived from standard echocardiography, cardiac magnetic resonance imaging and blood testing.

Countries

Germany

Contacts

Primary ContactPeter Nordbeck, MD, PhD
nordbeck_p@ukw.de+49 931 201 39181
Backup ContactKai Hu, MD
hu_k@ukw.de+49 931 201 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026